Literature DB >> 9024815

Hepatitis C virus genomic variability in untreated and immunosuppressed patients.

Z Lawal1, J Petrik, V S Wong, G J Alexander, J P Allain.   

Abstract

To investigate whether immune pressure enhances the genetic diversity of the hepatitis C virus (HCV) hypervariable region 1, nucleotide sequences were compared in multiple sera, collected longitudinally, from three untreated patients and four patients undergoing liver transplantation for HCV-related cirrhosis. A minor variant became dominant in three of three patients following transplantation and persisted unchanged for months. Compared with untreated HCV carriers, transplant recipients had fewer quasispecies, fewer nucleotide changes (1.61 and 2.58/month), fewer amino acid sequence changes (0.40 and 1.94/month), as well as higher ratio of transitional to transversional mutations (2.57 and 0.98, P < 0.02) and lower replacement to silent mutations (1.33 and 8.21, P < 0.01). The two patients with the least genomic variation died of HCV graft infection. The data suggest that HCV variants which infect the graft are selected by recipient immune pressure at the time of transplant and that preferential replication in the graft is enhanced by routine immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024815     DOI: 10.1006/viro.1996.8359

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1.

Authors:  C Li; D Candotti; J P Allain
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters.

Authors:  J P Allain; Y Dong; A M Vandamme; V Moulton; M Salemi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection.

Authors:  A Manzin; L Solforosi; M Debiaggi; F Zara; E Tanzi; L Romanò; A R Zanetti; M Clementi
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Evolution of hypervariable region 1 of hepatitis C virus in primary infection.

Authors:  A Manzin; L Solforosi; E Petrelli; G Macarri; G Tosone; M Piazza; M Clementi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa.

Authors:  Daniel Candotti; Jillian Temple; Francis Sarkodie; Jean-Pierre Allain
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

6.  Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.

Authors:  Jennifer M Babik; Mark Holodniy
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 7.  HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.

Authors:  Giuseppe Sautto; Nicasio Mancini; Laura Solforosi; Roberta A Diotti; Massimo Clementi; Roberto Burioni
Journal:  Clin Dev Immunol       Date:  2012-05-29

Review 8.  Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

Authors:  Giuseppe Sautto; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-08       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.